Peg-IFNα-2b

DRUG2 trials

Sponsors

Beijing 302 Hospital

Conditions

Chronic Hepatitis B

Unknown Phase

The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients

Active, not recruitingNCT06357806

Beijing 302 HospitalChronic Hepatitis B

Start: 2024-05-17End: 2026-10-08Target: 45Updated: 2026-03-18

Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients

RecruitingNCT06457477

Beijing 302 HospitalChronic Hepatitis B

Start: 2024-06-15End: 2025-12-15Target: 50Updated: 2024-06-20

Related Papers

Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial

BMJ Open2025-09-01